Mannatech (MTEX) AI Stock Analysis

• Market Cap: $16.54M
• Dividend Yield: N/A
• Average Volume (3M): 44.13K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.42
• Revenue Growth: -7.69%
• EPS Growth: -220.31%
• Country: US
• Employees: 189
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): -2.27
• Shares Outstanding: 1,900,930
• 10 Day Avg. Volume: 16,798
• 30 Day Avg. Volume: 44,128
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 1.09
• Enterprise Value/Revenue: 0.16
• Enterprise Value/Gross Profit: 0.21
• Enterprise Value/Ebitda: -23.65
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 49 Neutral
• Price Target: $9.00 ▼(-4.76% Downside)

Mannatech's overall stock score is primarily impacted by its financial performance challenges, including declining revenues and negative profitability. Technical analysis provides some positive signals with bullish momentum, but valuation concerns due to a negative P/E ratio and lack of dividend yield weigh heavily on the score.

Mannatech Business Overview & Revenue Model

Company Description

Mannatech, Incorporated (MTEX) is a global health and wellness company that specializes in the development and marketing of nutritional supplements, personal care products, and skincare solutions. Founded in 1994, the company is known for its innovative products that utilize glyconutritional technology. Mannatech operates primarily in the direct selling sector, empowering independent associates to market its products through various channels to consumers worldwide.

How the Company Makes Money

Mannatech generates revenue primarily through the sale of its health and wellness products, which include dietary supplements and personal care items. The company's direct selling model allows it to recruit independent associates who earn commissions on product sales, creating a multi-level marketing structure. This model not only drives product sales but also encourages associates to build their own networks, thereby increasing overall sales volume. Additionally, Mannatech may generate income through strategic partnerships and collaborations, enhancing product offerings and expanding market reach. The company also benefits from customer loyalty programs and repeat purchases from existing customers, which contribute to a stable revenue flow.

Mannatech Financial Statement Overview

Summary

Mannatech faces significant financial challenges with declining revenues and profitability issues. The balance sheet shows moderate leverage, but negative returns on equity are concerning. Cash flow improvements are noted, but the company needs to address operational inefficiencies to enhance financial health.

Income Statement

Mannatech's income statement shows declining revenue with a negative revenue growth rate of -1.79% TTM. The gross profit margin remains relatively strong at 75.79%, but the company is experiencing negative net profit margins, indicating losses. EBIT and EBITDA margins are also weak, reflecting operational challenges.

Balance Sheet

The balance sheet shows a moderate debt-to-equity ratio of 0.84, suggesting manageable leverage. However, the return on equity is negative, indicating inefficiencies in generating returns for shareholders. The equity ratio is not provided, limiting further analysis.

Cash Flow

Cash flow analysis reveals negative operating cash flow and free cash flow, although there is a significant improvement in free cash flow growth. The operating cash flow to net income ratio is negative, highlighting cash flow challenges. The free cash flow to net income ratio is relatively high, indicating some efficiency in converting income to cash.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	112.97M	117.87M	131.96M	137.21M	159.76M	151.41M
Gross Profit	84.92M	91.46M	102.86M	104.15M	125.61M	115.90M
EBITDA	-764.00K	5.55M	702.00K	1.26M	10.85M	6.52M
Net Income	-3.91M	2.49M	-2.24M	-4.49M	9.84M	6.26M
Balance Sheet
Total Assets	32.78M	36.06M	41.21M	49.13M	59.63M	65.34M
Cash, Cash Equivalents and Short-Term Investments	6.08M	11.40M	7.73M	13.78M	24.18M	22.21M
Total Debt	6.37M	6.69M	5.73M	6.17M	6.13M	8.95M
Total Liabilities	26.82M	27.44M	30.72M	34.95M	35.21M	39.36M
Stockholders Equity	5.96M	8.61M	10.48M	14.18M	24.41M	25.97M
Cash Flow
Free Cash Flow	-1.78M	1.96M	-3.12M	-3.66M	10.12M	5.08M
Operating Cash Flow	-2.03M	2.26M	-2.37M	-2.60M	10.77M	6.03M
Investing Cash Flow	-773.00K	-285.00K	-747.00K	-1.06M	-650.00K	-947.00K
Financing Cash Flow	-1.39M	1.96M	-1.90M	-4.33M	-9.29M	-9.92M

Mannatech Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 9.45
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MTEX, the sentiment is Negative. The current price of 9.45 is above the 20-day moving average (MA) of 9.05, above the 50-day MA of 8.88, and below the 200-day MA of 9.69, indicating a bearish trend. The MACD of 0.04 indicates Positive momentum. The RSI at 48.17 is Neutral, neither overbought nor oversold. The STOCH value of 31.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MTEX.

Mannatech Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NUS	―	$527.15M	5.36	13.68%	2.25%	-11.79%	―
EWCZ	―	$196.04M	17.56	10.98%	―	-5.04%	-22.01%
EPC	―	$880.96M	14.50	4.12%	3.11%	-2.92%	-43.06%
Sector *	―	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
TKLF	―	$14.01M	2.24	16.79%	―	7.75%	-21.61%
MTEX	―	$16.54M	-4.25	-55.19%	―	-7.69%	-220.31%
SKIN	―	$176.29M	-4.94	-26.54%	―	-15.33%	75.52%

Mannatech Corporate Events

Mannatech Extends Loan Repayment to March 2027

On September 9, 2025, Mannatech, Incorporated entered into Loan Extension Agreements with three board members and stockholders, extending the repayment of $3.6 million in loans to March 31, 2027. This extension allows Mannatech additional time to use the funds for general working capital needs, with the option to prepay without penalty.

The most recent analyst rating on (MTEX) stock is a Hold with a $8.50 price target. To see the full list of analyst forecasts on Mannatech stock, see the MTEX Stock Forecast page.

Mannatech Inc. Braces for Profitability Challenges Amid Potential Tariff Changes

Mannatech Inc. faces significant risks to its profitability and market competitiveness due to potential changes in trade policies, including tariffs. The imposition of new tariffs or increases in existing ones between key trading partners like the United States, Mexico, and China could escalate costs and disrupt supply chains. Despite efforts to mitigate these impacts, such as shifting production locations, the company may struggle with operational complexities and competitive pressures. This could lead to increased prices, potential loss of customers, and adverse effects on revenue and market position.

Mannatech Inc. Reports Decline in Quarterly Earnings

Mannatech Inc., a Texas-based company listed on the Nasdaq, specializes in the development, marketing, and sale of nutritional supplements, skin care, anti-aging, and weight-management products across various global regions. In its latest earnings report for the quarter ended June 30, 2025, Mannatech Inc. reported a decline in net sales to $25.7 million from $27.7 million in the same period last year, resulting in a net loss of $4.3 million compared to a loss of $624,000 in the previous year. The company’s gross profit also decreased to $18.9 million from $21.4 million, while operating expenses saw a slight reduction. Despite the challenging financial performance, Mannatech continues to focus on its strategic initiatives and product offerings. Looking forward, the company remains committed to navigating market challenges and leveraging its global presence to drive growth and improve financial outcomes.